Philippart François, Bouroche Gaëlle, Timsit Jean-François, Garrouste-Orgeas Maité, Azoulay Elie, Darmon Michael, Adrie Christophe, Allaouchiche Bernard, Ara-Somohano Claire, Ruckly Stéphane, Dumenil Anne-Sylvie, Souweine Bertrand, Goldgran-Toledano Dany, Bouadma Lila, Misset Benoît
Medical-Surgical ICU, Groupe Hospitalier Paris Saint Joseph, Paris, France.
Department of Anesthesia and Intensive Care, Gustave Roussy Institute, Villejuif, France.
PLoS One. 2015 Sep 4;10(9):e0137262. doi: 10.1371/journal.pone.0137262. eCollection 2015.
Experimental studies suggest that intra-abdominal infection (IAI) induces biological alterations that may affect the risk of lung infection.
To investigate the potential effect of IAI at ICU admission on the subsequent occurrence of ventilator-associated pneumonia (VAP).
We used data entered into the French prospective multicenter Outcomerea database in 1997-2011. Consecutive patients who had severe sepsis and/or septic shock at ICU admission and required mechanical ventilation for more than 3 days were included. Patients with acute pancreatitis were not included.
Of 2623 database patients meeting the inclusion criteria, 290 (11.1%) had IAI and 2333 (88.9%) had other infections. The IAI group had fewer patients with VAP (56 [19.3%] vs. 806 [34.5%], P<0.01) and longer time to VAP (5.0 vs.10.5 days; P<0.01). After adjustment on independent risk factors for VAP and previous antimicrobial use, IAI was associated with a decreased risk of VAP (hazard ratio, 0.62; 95% confidence interval, 0.46-0.83; P<0.0017). The pathogens responsible for VAP were not different between the groups with and without IAI (Pseudomonas aeruginosa, 345 [42.8%] and 24 [42.8%]; Enterobacteriaceae, 264 [32.8%] and 19 [34.0%]; and Staphylococcus aureus, 215 [26.7%] and 17 [30.4%], respectively). Crude ICU mortality was not different between the groups with and without IAI (81 [27.9%] and 747 [32.0%], P = 0.16).
In our observational study of mechanically ventilated ICU patients with severe sepsis and/or septic shock, VAP occurred less often and later in the group with IAIs compared to the group with infections at other sites.
实验研究表明,腹腔内感染(IAI)会引发可能影响肺部感染风险的生物学改变。
研究入住重症监护病房(ICU)时的IAI对随后发生呼吸机相关性肺炎(VAP)的潜在影响。
我们使用了1997年至2011年录入法国前瞻性多中心Outcomerea数据库的数据。纳入了入住ICU时患有严重脓毒症和/或感染性休克且需要机械通气超过3天的连续患者。排除急性胰腺炎患者。
在2623例符合纳入标准的数据库患者中,290例(11.1%)患有IAI,2333例(88.9%)患有其他感染。IAI组发生VAP的患者较少(56例[19.3%]对806例[34.5%],P<0.01),且发生VAP的时间更长(5.0天对10.5天;P<0.01)。在对VAP的独立危险因素和既往抗菌药物使用情况进行调整后,IAI与VAP风险降低相关(风险比,0.62;95%置信区间,0.46 - 0.83;P<0.0017)。IAI组和非IAI组中导致VAP的病原体无差异(铜绿假单胞菌分别为345例[42.8%]和24例[42.8%];肠杆菌科分别为264例[32.8%]和19例[34.0%];金黄色葡萄球菌分别为215例[26.7%]和17例[30.4%])。IAI组和非IAI组的ICU粗死亡率无差异(81例[27.9%]和747例[32.0%],P = 0.16)。
在我们对患有严重脓毒症和/或感染性休克的机械通气ICU患者的观察性研究中,与其他部位感染组相比,IAI组VAP的发生频率更低且更晚。